Zika Virus Testing Market Research Report Information By Tests Include (serological/Zika virus antibody and molecular/nucleic acid amplification), End-Users (Diagnostic units, hospitals, pathology labs), Regions (Asia Pacific, Europe, Americas, and the Middle East and Africa) Forecast till 2030

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Technique

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL ZIKA VIRUS TESTING MARKET , BY TESTS

6.1. Overview

6.2. Serological/Zika Virus Antibody

6.3. Molecular/Nucleic Acid Amplification

7. GLOBAL ZIKA VIRUS TESTING MARKET , BY END USER

7.1. Overview

7.2. Diagnostic Units

7.3. Hospitals

7.4. Pathology Labs

8. GLOBAL ZIKA VIRUS TESTING MARKET , BY REGION

8.1. Overview

8.1. North America

8.1.1. US

8.1.2. Canada

8.2. Europe

8.2.1. Germany

8.2.2. France

8.2.3. UK

8.2.4. Italy

8.2.5. Spain

8.2.6. Rest of Europe

8.3. Asia-Pacific

8.3.1. China

8.3.2. India

8.3.3. Japan

8.3.4. South Korea

8.3.5. Australia

8.3.6. Rest of Asia-Pacific

8.4. Rest of the World

8.4.1. Middle East

8.4.2. Africa

8.4.3. Latin America

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Zika Virus Testing Market

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of Number of Developments in the Global Zika Virus Testing Market

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch

9.7.2. Merger & Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix

9.8.1. Sales & Operating Income, 2022

9.8.2. Major Players R&D Expenditure. 2022

10. COMPANY PROFILES

10.1. Luminex Corporation

10.1.1. Company Overview

10.1.2. Financial Overview

10.1.3. Product Offered

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. ARUP Laboratories

10.2.1. Company Overview

10.2.2. Financial Overview

10.2.3. Product Offered

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Roche Molecular Systems

10.3.1. Company Overview

10.3.2. Financial Overview

10.3.3. Product Offered

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Hologic

10.4.1. Company Overview

10.4.2. Financial Overview

10.4.3. Product Offered

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Siemens Healthcare Diagnostics.

10.5.1. Company Overview

10.5.2. Financial Overview

10.5.3. Product Offered

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Emergent BioSolutions Inc

10.6.1. Company Overview

10.6.2. Financial Overview

10.6.3. Product Offered

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Valneva SE

10.7.1. Company Overview

10.7.2. Financial Overview

10.7.3. Product Offered

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Moderna

10.8.1. Company Overview

10.8.2. Financial Overview

10.8.3. Product Offered

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Novavax ,Inc.

10.9.1. Company Overview

10.9.2. Financial Overview

10.9.3. Product Offered

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Johnson & Johnson Private Limited.

10.10.1. Company Overview

10.10.2. Financial Overview

10.10.3. Product Offered

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL ZIKA VIRUS TESTING MARKET , SYNOPSIS, 2019–2032

TABLE 2 GLOBAL ZIKA VIRUS TESTING MARKET , ESTIMATES & FORECAST, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL ZIKA VIRUS TESTING MARKET , BY REGION, 2019–2032 (USD MILLION)

TABLE 6 NORTH AMERICA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 7 NORTH AMERICA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 8 NORTH AMERICA: ZIKA VIRUS TESTING MARKET , BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 9 US: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 10 US: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 11 CANADA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 12 CANADA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 13 EUROPE: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 14 EUROPE: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 15 EUROPE: ZIKA VIRUS TESTING MARKET , BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 16 GERMANY: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 17 GERMANY: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 18 FRANCE: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 19 FRANCE: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 20 ITALY: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 21 ITALY: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 22 SPAIN: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 23 SPAIN: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 24 UK: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 25 UK: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 26 REST OF EUROPE: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 27 REST OF EUROPE: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 28 ASIA-PACIFIC: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 29 ASIA-PACIFIC: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 30 ASIA-PACIFIC: ZIKA VIRUS TESTING MARKET , BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 31 JAPAN: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 32 JAPAN: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 33 CHINA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 34 CHINA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 35 INDIA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 36 INDIA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 37 AUSTRALIA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 38 AUSTRALIA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 39 SOUTH KOREA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 40 SOUTH KOREA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 41 REST OF ASIA-PACIFIC: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 42 REST OF ASIA-PACIFIC: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 43 REST OF THE WORLD: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 44 REST OF THE WORLD: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 45 REST OF THE WORLD: ZIKA VIRUS TESTING MARKET , BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 46 MIDDLE EAST: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 47 MIDDLE EAST: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 48 AFRICA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 49 AFRICA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

TABLE 50 LATIN AMERICA: ZIKA VIRUS TESTING MARKET , BY TEST, 2019–2032 (USD MILLION)

TABLE 51 LATIN AMERICA: ZIKA VIRUS TESTING MARKET , BY END USER, 2019–2032 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ZIKA VIRUS TESTING MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ZIKA VIRUS TESTING MARKET

FIGURE 4 GLOBAL ZIKA VIRUS TESTING MARKET , SHARE (%), BY TEST, 2022

FIGURE 5 GLOBAL ZIKA VIRUS TESTING MARKET , SHARE (%), BY END USER, 2022

FIGURE 6 GLOBAL ZIKA VIRUS TESTING MARKET , SHARE (%), BY REGION, 2022

FIGURE 7 NORTH AMERICA: ZIKA VIRUS TESTING MARKET , SHARE (%), BY COUNTRY, 2022

FIGURE 8 EUROPE: ZIKA VIRUS TESTING MARKET , SHARE (%), BY COUNTRY, 2022

FIGURE 9 ASIA-PACIFIC: ZIKA VIRUS TESTING MARKET , SHARE (%), BY COUNTRY, 2022

FIGURE 10 REST OF THE WORLD: ZIKA VIRUS TESTING MARKET , SHARE (%), BY COUNTRY, 2022

FIGURE 11 GLOBAL ZIKA VIRUS TESTING MARKET : COMPANY SHARE ANALYSIS (%), 2022

FIGURE 12 LUMINEX CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 13 LUMINEX CORPORATION: SWOT ANALYSIS

FIGURE 14 ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 15 ARUP LABORATORIES: SWOT ANALYSIS

FIGURE 16 ROCHE MOLECULAR SYSTEMS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 17 ROCHE MOLECULAR SYSTEMS: SWOT ANALYSIS

FIGURE 18 HOLOGIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 HOLOGIC : SWOT ANALYSIS

FIGURE 20 SIEMENS HEALTHCARE DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 SIEMENS HEALTHCARE DIAGNOSTICS: SWOT ANALYSIS

FIGURE 22 EMERGENT BIOSOLUTIONS INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 EMERGENT BIOSOLUTIONS INC: SWOT ANALYSIS

FIGURE 24 VALNEVA SE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 VALNEVA SE: SWOT ANALYSIS

FIGURE 26 MODERNA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 MODERNA: SWOT ANALYSIS

FIGURE 28 NOVAVAX,INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 NOVAVAX,INC.: SWOT ANALYSIS

FIGURE 30 JOHNSON & JOHNSON PRIVATE LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 JOHNSON & JOHNSON PRIVATE LIMITED: SWOT ANALYSIS